Frailty and sarcopenia: definitions and outcome parameters

Frailty and sarcopenia: definitions and outcome parameters

Detalhes bibliográficos
Main Authors:	Cooper, C, Dere, W, Evans, W, Kanis, J, Rizzoli, R, Sayer, A, Sieber, C, Kaufman, J, Abellan van Kan, G, Boonen, S, Adachi, J, Mitlak, B, Tsouderos, Y, Rolland, Y, Reginster, J
Formato:	Journal article
Publicado em:	2012

Registos relacionados

Tools in the assessment of sarcopenia.
Por: Cooper, C, et al.
Publicado em: (2013)

Quality of life in sarcopenia and frailty.
Por: Rizzoli, R, et al.
Publicado em: (2013)

Treatment of osteoporosis in men.
Por: Kaufman, J, et al.
Publicado em: (2013)

Management of glucocorticoid-induced osteoporosis.
Por: Rizzoli, R, et al.
Publicado em: (2012)

A reappraisal of generic bisphosphonates in osteoporosis.
Por: Kanis, J, et al.
Publicado em: (2012)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
Por: Rizzoli, R, et al.
Publicado em: (2011)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Por: Rizzoli, R, et al.
Publicado em: (2013)

Challenges for the development of bone-forming agents in Europe
Por: Kanis, J, et al.
Publicado em: (2014)

Challenges for the development of bone-forming agents in Europe.
Por: Kanis, J, et al.
Publicado em: (2014)

Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia
Por: Fougère Bertrand, et al.
Publicado em: (2015-01-01)

Sarcopenia in daily practice: assessment and management
Por: Beaudart, C, et al.
Publicado em: (2016)

Management of osteoporosis of the oldest old (vol 25, pg 2507, 2014)
Por: Rizzoli, R, et al.
Publicado em: (2014)

Retraction of: Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia
Por: Fougère Bertrand, et al.
Publicado em: (2020-09-01)

Partial adherence: a new perspective on health economic assessment in osteoporosis.
Por: Kanis, J, et al.
Publicado em: (2011)

Sarcopenia and the syndrome of frailty
Por: Ajay Kumar Gupta, et al.
Publicado em: (2016-01-01)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Por: Kanis, J, et al.
Publicado em: (2013)

Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Por: Anne Gingrich, et al.
Publicado em: (2019-04-01)

Aging, sarcopenia and the life-course
Por: Sayer, A, et al.
Publicado em: (2006)

The feasibility of assessing frailty and sarcopenia in hospitalised older people: a comparison of commonly used tools
Por: Kinda Ibrahim, et al.
Publicado em: (2019-02-01)

KAL'TsIY I VITAMIN D V VEDENIIOSTEOPOROZA
Por: R RIZZOLI, et al.
Publicado em: (2007-08-01)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Por: Kanis, J, et al.
Publicado em: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
Por: Kanis, J, et al.
Publicado em: (2008)

Sarcopenia and Frailty in Liver Cirrhosis
Por: Hiroki Nishikawa, et al.
Publicado em: (2021-04-01)

The International Osteoporosis Foundation: history, objectives and achievements.
Por: Cooper, C, et al.
Publicado em: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
Por: Cooper, C, et al.
Publicado em: (2009)

Nutrition, sarcopenia and frailty: an Asian perspective
Por: Woo, Jean, et al.
Publicado em: (2019)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Por: Rizzoli, R, et al.
Publicado em: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Por: Rizzoli, R, et al.
Publicado em: (2011)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
Por: Kanis, J, et al.
Publicado em: (2008)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
Por: Cooper, C, et al.
Publicado em: (2012)

Healthcare cost expenditures associated to frailty and sarcopenia
Por: Alejandro Álvarez-Bustos, et al.
Publicado em: (2022-09-01)

English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia
Por: Beaudart, C, et al.
Publicado em: (2016)

Sarcopenia, Frailty, and Diabetes in Older Adults
Por: Hak Chul Jang
Publicado em: (2016-04-01)

The frailty phenotype and sarcopenia: Similar but not the same
Por: Matteo Cesari
Publicado em: (2019-06-01)

Sarcopenia and frailty among the elderly population in the community: An observational study
Por: Nalina Gupta, et al.
Publicado em: (2024-07-01)

Health technology assessment in osteoporosis.
Por: Hiligsmann, M, et al.
Publicado em: (2013)

Comparison of the performance of five screening methods for sarcopenia
Por: Locquet M, et al.
Publicado em: (2017-12-01)

The developmental origins of sarcopenia.
Por: Sayer, A, et al.
Publicado em: (2008)

Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS).
Por: Patel, H, et al.
Publicado em: (2013)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
Por: Delmas, P, et al.
Publicado em: (2005)